HALO logo
halo search icon
BIOC
GlaxoSmithKline S.A.E.

BIOC · GlaxoSmithKline S.A.E.

330.00

EGP
-6.30 (-1.873%)
07/10/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

EGP29.24B

PE

48.50

EV/EBITDA

9.7

DIV Yield

2.5%

Payout Ratio

123%

MQV Rating

5Very Weak

As at 07/10/2026 12:00:00 AM

Price Chart

Description

GlaxoSmithKline (Egypt) engages in the pharmaceutical and healthcare business. Its business operations are carried out through the production, packaging, marketing, sale, and distribution of medicines and other pharmaceutical products. The company was founded on January 14, 1981 and is headquartered in Cairo, Egypt.

  • All-Companies
  • Big Candle
  • HALO 100
  • HALO 200
  • HALO All
  • HALO Price Momentum
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

-50.90%

EBITDA Margin

8.60%

Operating Cashflow

£267m

Free Cash Flow Return

25.10%

ROIC

3.20%

Interest Coverage

1.90

Quick Ratio

1.30

Performance

52 weeks range

Low 56 - 609

Trade Value (12mth)

US$159,121.00

1 week

32.81%

1 month

-21.32%

YTD

468.91%

1 year

843.69%

All time high

609.00

Additional Data

Shares Outstanding (Fully Diluted)

84m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

12-Jan-26

Next Dividend Pay Date

14-Jan-26

Reporting Currency

EGP

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of GlaxoSmithKline S.A.E. (BIOC:CAI)?
Halo FAQ
The current share price of GlaxoSmithKline S.A.E. (BIOC:CAI) is EGP£330.00.
2
What is the 52-week high share price for GlaxoSmithKline S.A.E. (BIOC:CAI)?
Halo FAQ
The 52-week high share price for GlaxoSmithKline S.A.E. (BIOC:CAI) is EGP£609.00.
3
What is the 52-week low share price for GlaxoSmithKline S.A.E. (BIOC:CAI)?
Halo FAQ
The 52-week low share price for GlaxoSmithKline S.A.E. (BIOC:CAI) is EGP£56.00.
4
What is the dividend yield for GlaxoSmithKline S.A.E. (BIOC:CAI)?
Halo FAQ
The current TTM dividend payout for GlaxoSmithKline S.A.E. (BIOC:CAI) is 2.50.
5
What was GlaxoSmithKline S.A.E. (BIOC:CAI) last dividend payment?
Halo FAQ
The last dividend payment of GlaxoSmithKline S.A.E. (BIOC:CAI) is EGP£1.00.
6
What is the franking level for GlaxoSmithKline S.A.E. (BIOC:CAI)?
Halo FAQ
GlaxoSmithKline S.A.E. (BIOC:CAI) has a franking level of 0.00%.
7
In which sector is GlaxoSmithKline S.A.E. (BIOC:CAI) classified?
Halo FAQ
GlaxoSmithKline S.A.E. (BIOC:CAI) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for GlaxoSmithKline S.A.E. (BIOC:CAI)?
Halo FAQ
The current P/E ratio for GlaxoSmithKline S.A.E. (BIOC:CAI) is 48.50.